6^th Pharmacovigilance Congress September 28-30, 2016 Toronto, Ontario, Canada

ConferenceSeries Ltd organizing gratifying Pharmaceutical conferences welcomes you to attend the 6th Pharmacovigilance Congress to be held during September 28-30, 2016 in Toronto, Canada focuses on the advancements in pharmacovigilance and risk management.

The field of Pharmacovigilance is growing rapidly and its development is making immense impacts in medical sciences and pharmaceuticals. 6^thPharmacovigilance Congress accentuate on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of 6^th Pharmacovigilance Congress is “Ensuring Drug Safety in Healthcare System”.

Track-1: Drug Safety:

Drug Safety (Pharmacovigilance) is the Pharmacological science relating to the collection, detection, determination, control, and inhibiting of adverse effects with Pharmaceutical products. In this Track it is discussed about the Drug Safety and its applications in various fields.

Track-2: Adverse Drug Reactions:

An Adverse Drug Reaction (ADR) is a response to drug which is noxious and unintended and which occurs at doses normally used in man for the prophylaxis, analysis, or therapy of disease or for the modification of physiological function. Many Adverse Drug Reactions represent an excess of the drug's therapeutic effects Manufacturers, professionals, and consumers should report Post Marketing Reports on adverse effects. How we reduce the adverse drug reactions is discussed in Reduction of adverse drug reaction by Nanotechnology topic.

Track 3: Pharmacovigilance Significance &Scope:

Pharmacovigilance and its Significance and Scope present the case for the importance of pharmacovigilance, to record its growth and potential as an important discipline within Medical science, and to describe its impact on patient welfare and public health and to know what is pharmacovigilance. In this track, we discussed about the Significance of pharmacovigilance. We also discussed on Pharmacovigilance role in healthcare system. Worldwide every year so many pharmacovigilance conferences were going on.

Track 4: Continental Pharmacovigilance:

Continental Pharmacovigilance gives an extension to Ensuring compliance with local and international requirements. To operate more efficaciously across multiple regions and Health authorities.

Track 5: Good Pharmacovigilance Practice:

Pharmacovigilance and Pharmacoepidemiology mainly deal to avoid the insufficient evidence of safety from clinical trials. To maintain the reporting practices avoid major problems in risk management. In addition, it is important to intensify on Signal investigation through observational studies and Interpreting safety signals. The pharmacovigilance Clinical Trials services companies must have the Pharmacovigilance Certification.

Track 6: Pharmacovigilance and Risk Management:

Pharmacovigilance and Risk Management plays major role in Drug industry. The new turn in Drug industry is to use Information technology in pharmacovigilance companies. Drug Industry need to promoting companies in pharmacovigilance practice and the Review of software’s used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in Risk Management. In this conferences so many experts from different Pharmacovigilance CRO’s, Pharmacovigilance service providers were participates and shares their knowledge and discusses about the new updates. In this year, there is an International conference on Pharmacovigilance 2016, which is held in Austria on September 19-21.

Track 7: Pharmacokinetics and Pharmacodynamics:

Drugs may undergo, Pharmacokinetics and Pharmacodynamics and Toxicity testing through animal testing. This data allows researchers to allometrically estimate a safe starting dose of the drug for clinical trials in humans. In this track mainly we focused on Advances in pharmacodynamics interactions, Drug and substance abuse, Drug-Drug Interactions. Also discussed about the Pharmacy Practices to maintain the Pharmacokinetics and Pharmacodynamics and its Challenges and its guidelines. There are several Challenges in compounding and dispensing practice in Pharmacokinetics and Pharmacodynamics.

Track 8: Pre-Clinical and Clinical Trials:

The main goals of Pre-Clinical and Clinical Trials are to determine the safe dose and start to assess product's safety profile. In Designing of trials, there are pre-clinical studies and different phases of clinical trials. In this trails they estimate the Bioassay and its types. The Data collection and quality control is the major part in Pre-Clinical and Clinical Trials. For some specific drugs, there are some Alternative trials designs and models are used. Pre-Clinical and Clinical Trials are conducted as Multi center trials and monitoring basis. Each Pre-Clinical and Clinical Trials study of a drug, biological product, or medical device regulated by the FDA must be reviewed, approved, and monitored by the Regulatory authorities and ethics committee. There are several types of clinical trials like Clinical Trials on drugs used in respiratory disorders. Advanced Information technology in clinical trials improves the quality of Pre-Clinical and Clinical Trials.

Track 9: Clinical Trials on Various Disorders:

Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics Emerging technology in clinical trials track mainly deals on the clinical trials in long chronic diseases and several disorders. In This track we discussed about the Recent clinical trials on AIDS, Clinical trials on benign and malignant tumours, Clinical trials on cardiovascular diseases, Clinical trials on diabetes, Clinical Trials of monoclonal and polyclonal antibodies, Clinical trials on drugs used in psychological disorders The current research mainly focus on Applications of Biomarkers in clinical trials.

Track 10: Clinical Research and Statistics:

In Clinical Research Statistics plays major role. Depends upon the Statistics the clinical trials go for regulatory submissions. There are several guidelines mainly ICH guidelines for clinical research and its statistics follow for the clinical research. Stastical analysis of past pharmacovigilance and Adverse Drug Reactions reports also consider for the regulatory submission.

Track 11: Case Report in Clinical Trials:

Case Report in Clinical Trials plays major role in clinical research. In this track we discussed about the several case reports like Cancer case reports, Cardiovascular trials case report, Case studies on sexually transmitted diseases, Case studies on type 1 and type 2 diabetes, Case reports on drugs used in pregnancy and lactation.

Track 12: Biopharmaceutics:

In Clinical Pharmacology and Bio pharmaceutics track we discussed about the Rational drug management of cancer, diabetes and cardiovascular disorders, and Management of psychiatric disorders and autoimmune disorders. Along with clinical trials Bioavailability and Bioequivalence studies also plays major role in clinical research.

Track 13: PV Data Base Management:

There is advantage in centralising all safety data, clinical data, analysis and reporting with one provider. Pharmacovigilance Software tool provides comprehensive analysis of adverse events arising from the use of pharmaceutical products (Medicinal Product, Medical Device, Vaccines, Non-Drug Therapy and Veterinary Medicinal Product). The Drug Safety database allows the risk- benefit analysis of medicinal products taking into account new and emerging information, in the context of cumulative information. Pharmacovigilance since beginning has been a compliance driven activity, wherein your regulatory compliance determines company’s Risk Assessment scores. A Drug Safety Database offers scheduling of alerts for expedited cases, follow-up cases and PSUR/PADER reports submission to meet regulatory timeline compliance.

Track 14: PV Consulting’s and Business opportunity:

Due to the changing resources necessary to fulfil the regulatory requirements, some companies also choose to outsource or out task Regulatory Affairs to external service providers. Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession. The stringent regulations on safety monitoring and their periodical revision have led to increased Safety Data collection, analysis and regulatory surveillance, and increased costs. Thus, Pharmacovigilance has become a critical phase in clinical development programs.

Track 15: Regulatory affairs:

Regulatory affairs for clinical trials is the major part in the clinical trials approaches. Every clinical trial must be conduct according to the Regulatory affairs guidelines. There are several Regulatory affairs depending upon the countries. Regulatory Affairs departments are growing within companies. Global harmonization in standards has led to consistent approach in regulatory submissions and hence its review.

Track 16: Growth strategies in Pharma:

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product surveillances. The updates and advances in Pharmacovigilance regulation system are discussed in Advances in changing pharmacovigilance regulation system track.

Track 17: Pharmacy Practices and its Challenges:

In Pharmacy Practices and its Challenges track mainly focused on Pharmacy practice and its guidelines and Challenges in compounding and dispensing practice. Dosage regimen, Drug Toxicity and drug safety measures place important position in clinical research.